Nörokardiyojenik Senkoplu Çocuk ve Adölesanlarda Tanı, Tedavi ve İzlem Sonuçlarının Değerlendirilmesi
Çocuk Dergisi / Journal of Child · 30.12.2010 · 10 (4) · 190-197
DOI: 10.5222/j.child.2010.190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Çocuk Dergisi / Journal of Child, online erschienen am 30.12.2010. Verfasst von Yakup Ergül und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Objective
To evaluate the response to treatment and longterm follow-up of the children with recurrent syncope who underwent a basal-isosorbide dinitrate (ISDN) stimulated head-up tilt table test (HUT)
Methods
The patients with recurrent syncope, excluding those with cardiac and neurologic etiologic factors underwent a HUT and followed up for at least one year while undergoing treatment. The age of the patients ranged between 9-18 years. In the HUT protocol, patients were evaluated at 70° angle for 30 minutes initially and if necessary, 400 µg ISDN spray was applied sublingually for 15 minutes.
Results
The study was performed on 61 patients. The mean age of the patients was 13.4±2 years and the mean number of recurrent syncopes was 3.8±2.8. The test was found to be positive on 45 patients (73.8 %) (19 basal-26 ISDN stimulated). Twenty-three patients were followed up with conservative therapy. Medical therapy was started on 38 patients [metoprolol, n= 31, and propranolol, n= 6), and combination therapy (metoprolol, midodrine, fludrocortisone and fluoxetine, n=1). In 8 out of 37 patients who were given betablocker therapy, mainly headache, and also abdominal pain, vomiting, depressive symptoms (n=1) were observed. The average follow- up period was 20±9 months. Syncope recurred in 7 patients. There was no significant difference between tilt test positive and negative groups and among patients either on medical therapy or not regarding to the recurrences of syncopes.
Conclusion
ISDN stimulated tilt test protocol can be performed in pediatric patients with diagnoses of recurrent and unexplained syncope. However it has not been found to be predictive for the risk of recurrences. We believe that further studies are needed to document the benefit of medical therapy to prevent the recurrent syncope episodes..
Zitieren
APA
Ergül, Y., Nişli, K., Rahimov, E., Özcan, E. E., Aydoğan, Ü., Ömeroğlu, R. E., & Dindar, A. (2010). Nörokardiyojenik Senkoplu Çocuk ve Adölesanlarda Tanı, Tedavi ve İzlem Sonuçlarının Değerlendirilmesi. Çocuk Dergisi / Journal of Child, 10(4), 190-197. https://doi.org/10.5222/j.child.2010.190
Vancouver
Ergül Y, Nişli K, Rahimov E, Özcan EE, Aydoğan Ü, Ömeroğlu RE, et al. Nörokardiyojenik Senkoplu Çocuk ve Adölesanlarda Tanı, Tedavi ve İzlem Sonuçlarının Değerlendirilmesi. Çocuk Dergisi / Journal of Child. 2010;10(4):190-197. doi:10.5222/j.child.2010.190
BibTeX
@article{Ergl2010,
author = {Ergül, Yakup and Nişli, Kemal and Rahimov, Erkin and Özcan, Elif Erdem and Aydoğan, Ümrah and Ömeroğlu, Rukiye Eker and Dindar, Aygün},
title = {Nörokardiyojenik Senkoplu Çocuk ve Adölesanlarda Tanı, Tedavi ve İzlem Sonuçlarının Değerlendirilmesi},
journal = {Çocuk Dergisi / Journal of Child},
year = {2010},
volume = {10},
number = {4},
pages = {190--197},
doi = {10.5222/j.child.2010.190}
}
EUVIMED